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In 2001, the National Academy of Medicine set out its vision
to prioritise patient centred care: to ensure that clinical decisions
“respect patients’ wants, needs, and preferences and that patients
have the education and support they need to make decisions and
participate in their own care.”1 Similar aims also exist in UK
health strategy.2 Patient centred care is best delivered through
patient-clinician relationships that foster shared decision making;
an approach that has been shown to encourage health promoting
behaviours, reduce inappropriate or unnecessary use of care,
and improve patient and clinician satisfaction.3-5
Shared decision making and diagnosis
Shared decision making goes beyond simple information
exchange: it emphasises collaborative, often iterative,
deliberation between patients, family, and clinicians, to advance
the desired outcomes identified by the patient (fig 1⇓).6-10
This deliberation should cover patient preferences that are global
(such as the patient’s capacity and desire to be involved in
decision making) and specific (such as the patient’s concerns,
knowledge, and prior beliefs and preferences about specific
diseases or tests). The clinician should seek to understand the
patient in both the customary patient role and as a unique
individual whose personhood extends beyond their illness. Table
1⇓ shows the techniques that physicians can use to achieve the
goals of patient centred care
Despite the well recognised burden of diagnostic error and rising
use and cost of diagnostic tests,14-16 interventions to encourage
shared decision making have largely focused on screening and
treatment decisions. Meanwhile, the importance of shared
decision making in diagnostic decisions has been relatively
neglected.
Although the processes of diagnosis and treatment are not
completely decoupled, shared decision making for diagnosis
has distinct considerations (table 2⇓). A key difference is the
nature of the patient’s concerns; treatment decisions assume an
existing condition, whereas diagnostic situations require
clarification of the condition; for example, “my child fell and
hit his head, does he need a brain scan?” This difference is
critical, because uncertainty is often much greater for diagnosis
than treatment, making it much more challenging to explain the
options and weigh the risks and benefits to the patient.
Managing the wide array of diagnostic possibilities for an
undifferentiated symptom is also complicated by a patient’s
tolerance of uncertainty, how they as individuals manage
trade-offs between false negative and false positive results, and
how they act on test results. Precisely quantified benefits and
harms are less likely to be available for diagnosis than
treatment,18 especially with respect to incidental or false positive
results. This is sometimes referred to as the “cascade effect,”),
in which initial, smaller scale decisions give rise to a chain of
diagnostic procedures that might be unwarranted in hindsight.24
Additionally, a patient’s values and preferences might be
unstable, undefined, evolving, or difficult to express verbally
or explicitly: patients may just have a “gut feeling” about a
decision that is hard to articulate.25 As a result, decision making
for diagnosis is often more iterative than for treatment, and may
need to happen over an extended period of time.
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Key messages
Patient centred diagnosis is best practised through shared decision making; an iterative dialogue between doctor and patient, which
respects a patient’s needs, values, preferences, and circumstances
Shared decision making for diagnostic situations differs fundamentally from that for treatment decisions. This has important implications
when considering its practical application
The nature of dialogue should be tailored to the specific diagnostic decision; scenarios with higher stakes or uncertainty usually require
more detailed conversations
The nature, detail, and depth of the shared decision making
process depends on the unique characteristics of the patient and
the clinical context; uncertainty intolerable to a doctor might
be tolerable to a patient, and a high stakes decision for one
patient might be a moderate or low stakes decision for another.
Diagnostic uncertainty includes incomplete information (such
as early manifestations or common, undifferentiated symptoms),
limited evidence (including unknown diagnostic test sensitivity
and specificity), or unclear impact of patient preferences on
appropriate choice of diagnostic strategies for achieving the
patients’ health goals. Stakes refer to the potential impact of
benefits or harms of diagnostic workups on outcomes that matter
to patients.
Uncertainty and stakes should be viewed through meaningful
conversation with the patient. How they should guide the
intensity of conversations (fig 2⇓; appendix) is explored below
in a series of case studies.
Case studies
For routine diagnostic cases or, more broadly, when uncertainty
and risks of testing are both low, clinicians should focus on
conveying in a straightforward manner the value of the
diagnostic procedure (box 1).
Clinicians should seek to obtain the patient’s consent to proceed
with testing but need not generally engage in deeper, more
detailed shared decision making dialogue unless the patient
hesitates, hedges, or declines (box 2).
If patient preferences for a particular test are known to be highly
variable—such as genetic testing for untreatable diseases or
procedures that might have high out-of-pocket costs for a
patient—more extensive dialogue is appropriate, regardless of
the certainty of benefits and harms of a work-up (box 3).
When knowledge of the benefits or harms of diagnostic
evaluation is highly uncertain or moderately certain evidence
favours neither choice, —a deeper, more detailed, and iterative
shared decision making process becomes essential (box 4).
In some scenarios, such as in emergency care, high stakes and
high levels of uncertainty are coupled with time pressure. In
these scenarios shared decision making faces unique challenges
and assumes even greater importance (box 5).
Conclusion and future research
The cases above illustrate how evidence and values (from both
patient and clinician) can interact to affect uncertainty, and
provide clinical examples where detailed shared decision making
is integral for achieving patient centred diagnosis. Centring
diagnostic decision making around the patient has the potential
to improve diagnostic safety and quality,29 and align diagnostic
strategies with patient values and preferences.30 The growing
science of patient reported outcomes may inform our
understanding of how to best incorporate patient preferences
explicitly into shared decision making for diagnosis.31
Recognition of the economic forces driving diagnostic
testing—and a better understanding of how these could be
integrated with a patient-centred approach— would help foster
the routine use of shared decision making in diagnostic
practice.32
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Box 1: Temporal headache
A 75 year old man who lives independently and whose only medical problem is mild osteoarthritis is seen in primary care with bitemporal
headaches and jaw claudication. The clinician suspects giant cell arteritis and plans to order an erythrocyte sedimentation rate test. She
explains her diagnostic suspicion to the patient in plain language and her rationale for ordering the test. She offers the patient the opportunity
to provide further input or ask any questions he or his family might have.
Discussion
Extensive shared decision making has no substantial role here, for several reasons. Firstly, the patient’s symptoms are highly indicative of
a dangerous disorder that can cause major harm (blindness). Secondly, the disease is treatable, and there is general consensus that the
benefits of treatment outweigh the harms. Thirdly, the test (venepuncture) contributes to the diagnosis, is low cost, and is nearly free of risk.
Lastly, not ordering the test is considered medically negligent. The contextual features of this encounter make it highly improbable that any
patient’s values and preferences (however extreme) would over-ride the strong rationale for ordering the test. Effective communication
between patient and physician is still important, but the shared decision making conversation need not be conducted in great depth or detail.
Box 2: Low back pain
A 53 year old man presents with a one week history of low back pain after lifting heavy furniture. After taking a history and physically examining
the patient, the clinician finds no abnormal neurological signs. She recommends that the patient apply heat, sleep comfortably, and take
over the counter analgesics as needed. The patient expresses worry and is uncomfortable that no further tests are performed. He requests
magnetic resonance imaging (MRI) of the back “just to be sure that nothing is wrong.” Using best available evidence, the clinician uses
patient centred care techniques (table 1⇓) to discourage testing, explaining that the image is more likely to give false positive findings than
to identify an important medical problem. The patient is visibly distressed and anxious and stops talking. The clinician invites the patient to
express his concerns and fears; he discloses that his sibling was recently diagnosed as having renal cancer, which first manifested with
lower back pain.
Discussion
The general medical consensus is that, in the absence of neurological abnormalities, computed tomography and MRI are unnecessary for
lower back pain and potentially harmful, given the small risks inherent with imaging plus the potential harms of downstream treatment for
incidental findings. The patient expressed a strong and repeated desire for further diagnostic testing, which might be based on values,
knowledge, or past experiences that the clinician has not fully explored. The clinician should use shared decision making techniques (table
1⇓) to ensure that she is fully aware of what the patient understands about the nature of his pain, about the benefits and risks of imaging,
and the patient’s underlying fears. This does not imply that diagnostic testing should be pursued—the end result of shared decision making
must be to avoid imaging that is not medically indicated. The aim is to further the conversation and make a decision based on a deeper
exploration of the patient’s concerns. Although the clinician should discourage imaging procedures that are not based on evidence, the
decision should reflect the specific preferences and needs of this unique patient.26 Learning about the recent diagnosis of renal cancer in a
sibling might lead to an entirely different, jointly developed diagnostic plan, such as urinalysis and imaging of the kidneys if the urinalysis
shows evidence of microscopic haematuria.
Box 3: Family history of Huntington’s disease
At a routine visit, a 25 year old woman tells her GP that her father was recently diagnosed as having Huntington’s disease after showing
neurological symptoms. She says that she is hesitant to get screened for the disease because she is scared of what will happen to her life
if she finds out that she carries the gene defects.
Discussion
Screening for genetic diseases such as Huntington’s disease is controversial and complicated. Patients might choose to avoid learning their
genetic status because of how the knowledge might affect their daily life; they might fear social stigma or experience personal frustration
with an untreatable, inevitable health condition. The patient may be concerned that their knowledge of a future onset of a devastating disease
might affect their employment or insurance. Evidence links the diagnosis with an increased risk of suicide. Some patients may decide not
to have children. The clinician should recognise that these complex concerns, values and preferences may change, perhaps under different
life circumstances, and should therefore be ready to modify the diagnostic plan accordingly.
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Box 4: Thunderclap headache
A 27 year old woman presents to the emergency department with an intense, throbbing headache for the past 24 hours. She does not
remember exactly how it started but notes that it built to maximum intensity within minutes. She has had headaches seven or eight times in
the past year and has been diagnosed with migraines. These previous episodes have lasted up to 12 hours, and she is usually able to
manage the symptoms with over the counter ibuprofen and resting in a quiet, dark room until the pain subsides. This time, however, the
pain was more rapid in onset and more intense than any headache she can remember. The pain is not relieved by drug treatment. She has
vomited twice since the episode began, which has never happened before. She has had no recent trauma that she can recall. A careful
physical examination shows no focal neurological abnormalities. She is taken for immediate computed tomography (CT), which shows no
evidence of subarachnoid haemorrhage or other intracranial pathology. She is observed in a quiet, unlit room and given intravenous fluids,
a dopamine receptor antagonist, and a non-steroidal anti-inflammatory drug. The patient reports feeling better in several hours and meets
with the attending physician to discuss the appropriate next steps.
At this encounter, the doctor seeks to build rapport with the patient. The patient notes that her migraines have forced her to consult regularly
with neurologists and says that she is tired of repeated diagnostic tests that don’t relieve her pain. The doctor acknowledges her frustration
and explains that the gold standard diagnostic approach for an intense sudden onset headache with negative CT results is a lumbar puncture.
He also says that, although the diagnostic value of lumbar puncture after negative CT is debated in this clinical context, his personal tendency
with previous patients has been to pursue further testing. Given the high stakes of the diagnostic situation, and high uncertainty, the patient
and doctor develop and agree on a diagnostic plan. They discuss the data on how accurately clinical features and CT scans detect
subarachnoid haemorrhage and consider several diagnostic options, including lumbar puncture, other imaging (such as CT angiography or
MRI with angiography), and watchful waiting. After thoroughly discussing the potential benefit and consequences of each approach, the
patient and doctor agree to pursue watchful waiting to reduce the burden of additional diagnostic testing on the patient. She is then discharged
after migraine management counselling.
The patient presents three months later for follow-up with her GP. She reports that she has continued to have migraine episodes, at greater
frequency than before the recent acute event, though none had the intensity that brought her to the emergency department—these are
reasonably well controlled with medication. She tells the GP that she read online that recurrent headaches might be symptomatic of brain
tumours and asks if she should be concerned. She denies any weight loss, constitutional symptoms, vision changes, seizures, or other
neurological symptoms. The GP agrees that a CT scan might have missed a small intracranial tumour that could potentially be detected by
other means, such as MRI. He also explains the possibility for MRI to pick up incidental findings that could lead to unnecessary treatment.
He recommends forgoing MRI for now with a plan to revisit if the patient presents with new neurological symptoms. The patient is fine with
this plan and thanks the physician for answering her question. They agree to follow-up every three months or if any new symptoms arise.
Discussion
Even though migraines are the most likely diagnosis in this case, brain aneurysms and brain tumours are most common among dangerous
mimics. Worsening or ongoing headaches may bring rare, dangerous disorders into consideration, such as dural arteriovenous malformation
(requiring catheter angiography for diagnosis) or isolated central nervous system vasculitis (for which no test or combination of diagnostic
tests, including neuroimaging, lumbar puncture, conventional angiography, and brain biopsy, is definitive).
Problems like this are difficult to formulate, even for the clinician, and are even more challenging to discuss with the patient. Even if the
diagnostic quandary is artificially constrained to reflect only the differential diagnosis of migraine versus aneurysm, there may be patient
specific diagnostic parameters for which no evidence exists. What is the likelihood of aneurysmal subarachnoid haemorrhage in a patient
with previous migraine, new thunderclap type, worst ever headache, first ever vomiting, with negative CT at 24 hours, no lumbar puncture
result, responsive to treatment, but then increased frequency (but not severity) of headaches without new neurological symptoms? Patients
with previous migraine were excluded from critical studies establishing clinical prediction rules for aneurysms in patients with acute headache.
Each patient’s story has nuances that might be pertinent (eg, greater frequency but not severity afterwards) but cannot readily be translated
into firm, probabilistic estimates.
With multiple possible diagnoses and next steps, the overall decision tree becomes complex and uncertain. After deciding to pursue tests
rather than watchful waiting, the doctor and patient must decide the sequence of tests and any stopping rules; for example, whether to do
MRI plus magnetic resonance angiography first and stop if the results are negative; go straight to catheter angiography, which has the
highest likelihood of ruling out all of the relevant dangerous disorders but has non-trivial risks; or do a lumbar puncture, which is less risky
and might distinguish xanthochromia from chronic bleeding or raised protein from low grade inflammation associated with vasculitis but is
insensitive and not definitive for any of the diagnoses in question.
The situation is further complicated by the differing psychology of decision making between doctor and patient. Clinicians might advocate
a risk averse approach to minimise harm through diagnostic error, whereas patients might want to avoid burdens or risks of diagnostic
procedures that provide no immediate relief of symptoms. These considerations are uniquely swayed by the values and goals of the patient
and must be discussed openly for shared decision making to be effective.
After making a diagnostic plan, the physician and patient must decide together when to transition away from further diagnostic tests and
towards treatment. This process might require explicit acknowledgment of acceptable levels of uncertainty. The transition from diagnosis to
treatment is not one way, and further considerations (such as new symptoms or the availability of new diagnostic technologies) might warrant
further diagnostic tests after treatment has started. The diagnostic process might be iterative and have an uncertain timeline or unclear
endpoint.
Box 5: Suspected stroke
An 82 year old woman staying in the hospital after surgery develops new weakness on the right hand side and confusion. A brain CT rules
out visible bleeding, and the emergency team want to give the patient alteplase within the three hour window for suspected stroke. The
patient’s family agrees that, if the patient is having a stroke, they favour treatment with alteplase, but they are concerned that she might not
be having a stroke, but rather experiencing side effects from pain drugs. They ask for further testing (such as MRI) to minimise the possibility
that the patient receives a high risk treatment for a wrong or highly uncertain diagnosis. These tests would delay giving alteplase, potentially
missing the therapeutic window and losing the option of effective treatment.
Discussion
Decision making in an emergency is fraught with complications. In this example, scientific evidence from treatment trials puts pressure on
the healthcare team to give a potentially dangerous treatment as fast as possible; the needs, values, and preferences of the family are
sometimes considered secondary or even an impediment to the medical goal.27 Yet, these situations, with high uncertainty and high stakes,
can benefit from more intensive shared decision making.
We strongly recommend that clinicians develop and implement formalised protocols for shared decision making with patients and their
families in emergency situations. This should include establishing roles for clinical personnel, effective communication of risks and constraints,
and the use of situation specific decision aids.28
Tables
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Table 1| Components of patient centred care, their goals, and relevant skills and techniques111213
Skills and techniquesPhysician goalsFunction
      Appropriate patient interaction (eg, greeting, eye contact)
      Active listening
      Body language conveying openness and warmth
      Joint agenda setting
      Build mutual trust and rapport with the patient
      Discuss roles and responsibilities of all participants (including
family)
      Respect autonomy and dignity of patient
Relationship building
      Ask open ended questions
      Active listening
      Repeat and summarise
      Have patient restate what they understood from the encounter
      Provide explanations without jargon
      Encourage questioning
      Encourage patients to explore other sources of information
      Understand the key medical and informational needs of the
patient
      Appreciate the patient's knowledge and beliefs about their health
      Share information in a manner accessible to and understandable
by the patient
      Empower patients to better use and evaluate information sources
Information exchange
      Legitimate and validate expressed emotions
      Demonstrate empathy
      Provide help in coping
      Recognise, understand, and empathise with the patient’s
emotions
Responding to patient
emotion
      Joint agenda setting
      Encourage patient participation in discussion
      Active listening
      Explore available options, including through the use of decision
aids
      Elicit patient goals and values
      Accommodate patient preferences
      Elucidate the patient’s needs, values, and preferences regarding
care, including desired degree of involvement in decision-making
      Deliberate with patient about available options and evidence
      Reach mutual agreement about desired course of action
Shared decision making
      Motivational interviewing
      Recommend and instruct patients through necessary steps
      Elicit patient goals and values
      Enable patient autonomy, motivation, and self efficacy
      Provide guidance, skills, and access to health resources
      Advocate for and assist patient in navigating healthcare system
Patient empowerment and
self management
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Table 2| Key differentiating features of shared decision making for diagnosis
Recommended actionConsiderations for the diagnostic encounterShared
decision
Shared
decision
Attribute
making for
diagnosis
making for
treatment
Context
Emphasise discussion of diagnostic possibilities
and work-up strategy rather than prognosis or
treatment for symptoms or underlying diseases
Goals of the conversation are focused (largely)
on determining causation, rather than finding
solutions
What is wrong
with me?
How can I get
better?
Patient’s primary
concern and goals of
the encounter
Clarify for the patient how you anticipate the
diagnostic process will unfold and over how long.
Define specific objectives for shared decision
making at each encounter and defer further
discussions until later, as appropriate
A correct diagnosis often unfolds over several
encounters over time. Shared decision making is
necessarily iterative, with new information
expected to influence later decision making
Often iterativeOften
compressed
Timeline and process
for decision making
Work with the patient to identify when they are ready
to move away from diagnosis towards symptom or
disease management. This will vary by disease and
by patient preference
Complete diagnostic certainty is rarely achieved.
An endpoint occurs when the search for a specific
diagnosis (or diagnostic confirmation) ends and
the focus shifts to prognosis and treatment
Diagnostic
uncertainty
resolved
sufficiently for
that patient
Most appropriate
treatment choice
for that patient
Endpoint of care
process
Evidence
Express higher levels of uncertainty and discuss
the patient’s overall health goals to determine
shared goals. This should help guide overall strategy
and choosing specific diagnostic tests or
consultations
The problem formulation is sometimes insufficient
to present options or choices, let alone weigh
risk-benefit probabilities
AmbiguousProbabilisticClarity of the problem
space or formulation 17
Reserve detailed shared decision making for specific
diagnostic test choices that have high stakes and
moderate uncertainty (fig 2⇓). Use less
time-intensive patient centred care strategies when
stakes are low or recommendations clear
The number of possible diseases (and test
options) is usually very high. Discussing all
medically reasonable considerations with the
patient or family is impractical (and potentially
overwhelming or frightening)
HigherLowerDecision tree complexity
Explain to the patient that identifying the cause of
their symptoms might not lead to a treatment benefit.
Discuss frankly the level of evidence that pursuing
a diagnosis will lead to improved outcomes that
matter. As appropriate, discuss overdiagnosis 19 20
and incidental findings as potential harms from
further diagnostic testing
The link between diagnostic strategy and patient
centred outcomes is usually remote. The strength
of evidence to guide choices is often low, requiring
a two step inference about the benefit of
diagnostic testing to the patient (For example,
does a test accurately diagnose disease X? If so,
is treatment Y beneficial in treatment of disease
LesserGreaterProximity to patient
centred outcomes and
strength of evidence
base
X?). This inference is weaker than a direct
inference18
Discuss uncertainty in diagnosis and the possibility
of diagnostic error. Emphasise the patient’s role in
prompt identification of misdiagnosis when red flags
appear or the disease course deviates from the
expected path
Diagnostic errors are more common and harmful
than treatment errors.21 Diagnostic decisions are
upstream, so inherently more uncertain and prone
to error than treatment decisions
HigherLowerRisk of medical error
Patient
Discuss patient values surrounding missed
opportunities to diagnose and treat.22 Discuss not
only the potential harms from testing but also the
potential for false positive test results in low risk
scenarios
Clinicians often make decisions based on needing
to know the cause first or ruling out the worst case
scenario, without explicitly considering the
downsides of further diagnostic testing or patient
risk preferences
Risk aversionRisk-benefit
trade-offs
Psychology of clinical
decision making
Discuss patient needs, values, and preferences
specifically related to trade-offs between the burden
of testing and resolution of diagnostic uncertainty
or fears
Diagnostic testing generally offers no tangible
(direct) benefit to patients, so, in some sense, is
“all risk and no reward”23
Largely
decoupled
Tightly coupledBurden of intervention
to the patient in relation
to their health outcome
Identify specific websites with reliable diagnostic
information or other patient resources (medical
librarians, second consultation services). Discuss
potential risks of using inadequately vetted internet
information or over-inferring diagnoses from
similarities with other patient symptoms
Diagnostic information on the internet for patients
with common symptoms is often inaccurate or
unreliable, and relevance of other patients’
experiences with the same symptoms is likely
lower than for those with the same disease
Less effectiveMore effectiveSelf efficacy and the
role of internet searches
and patient discussion
groups
For personal use only: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
BMJ 2017;359:j4218 doi: 10.1136/bmj.j4218 (Published 2017 November 01) Page 6 of 8
ANALYSIS
Figures
Fig 1 Conceptual model of patient centred diagnosis. Clinical context includes the presenting patient concern, the clinician’s
role, and the clinical setting. Considering this and the patient’s (or family’s) overall goals of care, a dialogue between clinician
and patient or family should be used to agree on a patient centred diagnostic plan.
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Fig 2 Framework for adjusting the intensity of shared decision making in patient centred diagnosis based on uncertainty
and stakes. When the potential benefit to patients is uncertain, and when diagnostic decisions have high stakes, clinicians
should engage in robust, detailed shared decision making with patients. SDM=shared decision making.
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